Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives
Antwi, Samuel O. , Rabe, Kari G. , Bamlet, William R. , Meyer, Margaret, Chandra, Shruti, Fagan, Sarah , Hu, Chunling, Couch, Fergus J., McWilliams, Robert R. , Oberg, Ann L. , Petersen, Gloria M., Chen, Chen , Fagan, Sarah E , Chaffee, Kari G. , Chen, C , Antwi, Samuel O , Bamlet, William R , McWilliams, Robert R , Meyer, Margaret, Chandra, Shruti, Hu, Chunling, Couch, Fergus J., Oberg, Ann L , Petersen, Gloria M.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 15, 2021 | Volume: 31 | Issue: 2 | Pages: 372-381

10.1158/1055-9965.epi-21-0745 | PMID 34782396 Get It

Abstract Background: ABO blood group is associated with pancreatic cancer risk. Whether ABO blood group alone or when combined with inherited mutation status of index pancreatic cancer cases (probands) can enhance pancreatic cancer risk estimation in first-degree relatives (FDR) is unclear. We examined FDRs' risk for pancreatic cancer based on probands' ABO blood group and probands' cancer susceptibility gene mutation status. Methods: Data on 23,739 FDRs, identified through 3,268 pancreatic cancer probands, were analyzed. Probands' ABO blood groups were determined serologically or genetically, and 20 cancer susceptibility genes were used to classify probands as “mutation-positive” or “mutation-negative.” SIRs and 95% confidence intervals (CI) were calculated, comparing observed pancreatic cancer cases in the FDRs with the number expected in SEER-21 (reference population). Results: Overall, FDRs had 2-fold risk of pancreatic cancer (SIR = 2.00; 95% CI = 1.79–2.22). Pancreatic cancer risk was higher in FDRs of mutation-positive (SIR = 3.80; 95% CI = 2.81–5.02) than mutation-negative (SIR = 1.79; 95% CI = 1.57–2.04) probands (P < 0.001). The magnitude of risk did not differ by ABO blood group alone (SIRblood-group-O = 1.57; 95% CI = 1.20–2.03, SIRnon-O = 1.83; 95% CI = 1.53–2.17; P = 0.33). Among FDRs of probands with non-O blood group, pancreatic cancer risk was higher in FDRs of mutation-positive (SIR = 3.98; 95% CI = 2.62–5.80) than mutation-negative (SIR = 1.66; 95% CI = 1.35–2.03) probands (P < 0.001), but risk magnitudes were statistically similar when probands had blood group O (SIRmutation-positive = 2.65; 95% CI = 1.09–5.47, SIRmutation-negative = 1.48; 95% CI = 1.06–5.47; P = 0.16). Conclusions: There is a range of pancreatic cancer risk to FDRs according to probands' germline mutation status and ABO blood group, ranging from 1.48 for FDRs of probands with blood group O and mutation-negative to 3.98 for FDRs of probands with non-O blood group and mutation-positive. Impact: Combined ABO blood group and germline mutation status of probands can inform pancreatic cancer risk estimation in FDRs.
Engineering Prone Patient Positioning for Spine Surgery to Reduce Risk of Clinician Injury
Lowndes, Bethany R. , Kraft, Sarah , Asiedu, Gladys B. , Woolley, Sandra M., Loynes, Lynn, Huddleston, Paul H., Huddleston, P.M. , Hallbeck, M. Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | November 12, 2021 | Volume: 65 | Issue: 1 | Pages: 515-519

10.1177/1071181321651274 Get It

Operating room throughput variability with spinal procedures revealed task inefficiency and potential safety concerns. Using the DMAIC framework (Define, Measure, Analyze, Improve, Control), a transdisciplinary team conducted a quality improvement (QI) research project to identify and address safety concerns with prone patient positioning. The main problem with patient positioning was undefined standard practice. Clinicians reported prone patient positioning for spinal surgery patients is physically demanding. Thus, the team conducted a rapid upper limb assessment for injury risk during patient positioning and identified a greater risk of clinician injury in the manual transfer process. The QI research team recommended the mechanical process of rotating patients with the Jackson Table to improve workload for the Surgical Team and developed training and design enhancements to support this workflow. The DMAIC quality framework enabled clinician collaboration with researchers to develop interventions to support a standardized process during prone patient positioning with the Jackson Table.
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Olsen, Elise A. , Whittaker, Sean , Willemze, Rein , Pinter‐Brown, Lauren , Foss, Francine M. , Schwartz, Lawrence , Guitart, Joan , Zic, John A., Wood, Gary S. , Ai, Wei , Gru, Alejandro A. , Guenova, Emmanuella , Hodak, Emmilia , Hoppe, Richard T. , Lechowicz, Mary Jo , Ortiz‐Romero, Pablo L. , Papadavid, Evangelia , Pittelkow, Mark R. , Prince, H. Miles , Sanches, José Antônio , Sugaya, Makoto , Vermeer, Maarten H. , Knobler, Robert , Stadler, Rudolf , Scarisbrick, Julia , Foss, Francine , Kim, Youn H , Gru, Alejandro , Guenova, Emmanuella , Ortiz-Romero, Pablo , Prince, H Miles , Sanches, Jose Antonio , Sugaya, Makoto , Vermeer, Maarten , Zain, Jasmine , Knobler, Robert , Stadler, Rudolf , Scarisbrick, Julia , Hoppe, Richard T , Geskin, Larisa J. , Horwitz, Sarah McCue , Duvic, Madeleine , Ai, Wei, Girardi, Michael , Kempf, Werner , Kim, Ellen , Quaglino, Pietro , Bagot, Martine

Mayo Clinic

Blood | November 11, 2021 | Volume: 140 | Issue: 5 | Pages: 419-437

10.1182/blood.2021012057 | PMID 34758074 Get It

Abstract The number of patients with primary cutaneous lymphoma (PCL) relative to other non-Hodgkin lymphomas (NHLs) is small and the number of subtypes large. Although clinical trial guidelines have been published for mycosis fungoides/Sézary syndrome, the most common type of PCL, none exist for the other PCLs. In addition, staging of the PCLs has been evolving based on new data on potential prognostic factors, diagnosis, and assessment methods of both skin and extracutaneous disease and a desire to align the latter with the Lugano guidelines for all NHLs. The International Society for Cutaneous Lymphomas (ISCL), the United States Cutaneous LymphomaConsortium (USCLC), and the Cutaneous Lymphoma Task Force of the European Organization for the Research and Treatment of Cancer (EORTC) now propose updated staging and guidelines for the study design, assessment, endpoints, and response criteria in clinical trials for all the PCLs in alignment with that of the Lugano guidelines. These recommendations provide standardized methodology that should facilitate planning and regulatory approval of new treatments for these lymphomas worldwide, encourage cooperative investigator-initiated trials, and help to assess the comparative efficacy of therapeutic agents tested across sites and studies.
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Fontana, Elisa , Meyers, Jeff, Sobrero, Alberto F. , Iveson, Timothy , Shields, Anthony F., Taı̈eb, Julien , Yoshino, Takayuki , Souglakos, Ioannis, Smyth, Elizabeth C., Lordick, Florian, Moehler, Markus , Giraut, Anne, Harkin, Andrea , Labianca, Roberto, Meyerhardt, Jeffrey, Boukovinas, Ioannis , Saunders, Mark, Vernerey, Dewi, Georgoulias, Vassilis, Ben‐Aharon, Irit , Shi, Qian , Meyerhardt, Jeffrey A. , Sobrero, Alberto , André, Thierry , Boukovinas, Ioannis , Lonardi, Sara , Oki, Eiji , Ben-Aharon, Irit , Shi, Qian , Meyerhardt, Jeffrey A , Iveson, Timothy J , Yoshino, Takayuki , Taieb, Julien , Fontana, Elisa , Meyers, Jeff, Shields, Anthony F., Souglakos, Ioannis, Smyth, Elizabeth C., Lordick, Florian, Moehler, Markus , Giraut, Anne, Harkin, Andrea , Labianca, Roberto, Saunders, Mark, Vernerey, Dewi, Georgoulias, Vassilis

Mayo Clinic

Journal of Clinical Oncology | November 9, 2021 | Volume: 39 | Issue: 36 | Pages: 4009-4019

10.1200/jco.21.02008 | PMID 34752136 Get It

PURPOSE Early-onset (EO) colorectal cancer (CRC, age < 50 years) incidence is increasing. Decisions on optimal adjuvant therapy should consider treatment adherence, adverse events, and expected outcomes in a population with life expectancy longer than later-onset (LO) CRC (age ≥ 50 years). MATERIALS AND METHODS Individual patient data from six trials in the International Duration Evaluation of Adjuvant Chemotherapy database were analyzed. Characteristics, treatment adherence, and adverse events in stage II or III EO-CRC and LO-CRC were compared. To reduce confounders of non–cancer-related deaths because of age or comorbidities, time to recurrence (3-year relapse-free rate) and cancer-specific survival (5-year cancer-specific mortality rate) were considered. RESULTS Out of 16,349 patients, 1,564 (9.6%) had EO-CRC. Compared with LO-CRC, EO-CRC had better performance status (86% v 80%, P < .01), similar T stage (% T1-3/T4: 76/24 v 77/23, P = .97), higher N2 disease rate (24% v 22%, P < .01), more likely to complete the planned treatment duration (83.2% v 78.2%, P < .01), and received a higher treatment dose intensity, especially with 6-month regimens. Gastrointestinal toxicity was more common in EO-CRC; hematologic toxicity was more frequent in LO-CRC. Compared with LO-CRC, significantly worse cancer-specific outcomes were demonstrated especially in high-risk stage III EO-CRC: lower 3-year relapse-free rate (54% v 65%; hazard ratio [HR] 1.33; 95% CI, 1.14 to 1.55; P value < .001) and higher 5-year cancer-specific mortality rate (24% v 20%; HR 1.21; 95% CI, 1.00 to 1.47; P value < .06). In this subgroup, no difference was observed with 3 or 6 months of therapy, with equally poor disease-free survival rates (57% v 56%; HR 0.97; 95% CI, 0.73 to 1.29; P value = .85). CONCLUSION Young age is negatively prognostic in high-risk stage III CRC and associated with significantly higher relapse rate; this is despite better treatment adherence and higher administered treatment intensity, suggesting more aggressive disease biology.
505 Relationship of infusion duration and dose to safety, efficacy and pharmacodynamics: second part of a phase 1–2 study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors
Powell, Steven , Strauss, James , Peng, Kah-Whye , Russell, Luke, Reckner, Monica, Wiegert, Erol , Bexon, Alice, Patel, Manish R. , Johnson, Melissa L. , Cripe, Timothy P. , Merchan, Jaime R.

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A537-A537

10.1136/jitc-2021-sitc2021.505 Get It

482 Phase1/2 study of an anti-galectin-9 antibody, LYT-200, in patients with metastatic solid tumors
Filipović, Aleksandra, Wainber, Zev, Bendell, Johanna C. , Jankú, Filip , Bolen, Joseph B., Elenko, Eric, Korth, C, Dranitsaris, George , Wang, Judy , Sharma, Manish R. , Mahipal, Amit , Korth, Christopher

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A512-A512

10.1136/jitc-2021-sitc2021.482 Get It

Risk Factors for Gastrointestinal Leak after Perforated Peptic Ulcer Disease Operative Repair
Lund, Sarah , Chauhan, Kiran Kaur, Zietlow, John , Stephens, Daniel , Zietlow, Scott P., Strajina, Veljko , Turay, David, Zielinski, Martin D. , Stephens, Daniel , Zietlow, Scott, Zielinski, Martin, Stephens, Daniel, Stephens, Daniel

Mayo Clinic

The American Surgeon™ | November 9, 2021 | Volume: 87 | Issue: 12 | Pages: 1879-1885

10.1177/00031348211056263 | PMID 34749511 Get It

Background There are limited studies regarding the impact of post-operative leak on perforated peptic ulcer disease (PPUD) and conflicting results regarding routine drain placement in operative repair of PPUD. This study aims to identify risk factors for gastrointestinal leak after operative repair of PPUD to better guide intra-operative decisions about drain placement. Methods We performed a retrospective cohort study at a tertiary care center from 2008 to 2019, identifying 175 patients who underwent operative repair of PPUD. Results Patients who developed a leak (17%) were compared to patients who did not. Both hypoalbuminemia (albumin < 3.5 g/dL) ( P = .03) and duodenal ulcers ( P < .01) were identified as significant risk factors for leak. No significant difference was found between leak and no leak groups for AAST disease severity grade, repair technique, or pre-operative use of tobacco, alcohol, or steroids. Post-operative leaks were associated with prolonged hospital stay (29 days compared to 10, P < .01), increased complication rates (77% compared to 48%, P < .01), and increased re-operation rates (73% compared to 26%, <0.01). No difference was identified in patient characteristics or operative leak rates between patients who had drains placed at the index operation and those that did not. Discussion Leak after operative PPUD repair is associated with significant post-operative morbidity. Hypoalbuminemia and duodenal perforations are significant risk factors for post-operative leaks.
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease
Nicholson, Maribeth R. , Alexander, Erin, Ballal, Sonia, Davidovics, Zev, Docktor, Michael , Dole, Michael , Gisser, Jonathan M., Goyal, Alka , Hourigan, Suchitra K. , Jensen, M. Kyle , Kaplan, Jess L. , Kelsen, Judith R. , Khanna, Sahil , Knackstedt, Elizabeth D , Lentine, Jennifer, Lewis, Jeffery D., Michail, Sonia , Mitchell, Paul D. , Patton, Tiffany , Queliza, Karen , Sidhu, Sarah , Solomon, Aliza , Suskind, David L. , Weatherly, Madison, Werlin, Steven L. , Zoeten, Edwin F. de , Kahn, Stacy A. , Group, North American Society of Pediatric Gastroenterology and Nutrition Faecal Microbiota Transplantation Special Interest, Aktay, Nur, Asbah, Imad, Bassett, Mikelle, Brumbaugh, David , Caicedo, Luis A. , Chawla, Anu, Conrad, Máire , Dykes, Chelly Dana, Grzywacz, Kelly, Gulati, Ajay, Gurram, Bhaskar , Hellman, Jenny, Kastl, Art, Mallon, Danny, Pai, Nikhil , Pasternak, Brad , Prozialeck, Josh, Reilly, Norelle R., Russell, George H., Singh, Namita , Small‐Harary, Lesley , Sood, Shilpa , Stumphy, Jessica, Sullivan, Jill M., Syed, Sabeen, Titgemeyer, Cebie, Townsend, Pete, Zheng, Yuhua , Suskind, David L , Alexander, Erin, Kellermayer, Richárd , Kennedy, Melissa A, Oliva‐Hemker, Maria , Group, North American Society of Pediatric Gastroenterology and Nutrition Faecal Microbiota Transplantation Special Interest, Bartlett, Mark, Caicedo, Luis, Gulati, Ajay, Patel, Ashish , Prozialeck, Joshua D. , Sood, Shilpa, Sullivan, Jill

Mayo Clinic

Journal of Crohn's and Colitis | November 8, 2021 | Volume: 16 | Issue: 5 | Pages: 768-777

10.1093/ecco-jcc/jjab202 | PMID 34788420 Get It

Abstract Background Children with inflammatory bowel disease [IBD] are disproportionally affected by recurrent Clostridioides difficile infection [rCDI]. Although faecal microbiota transplantation [FMT] has been used with good efficacy in adults with IBD, little is known about outcomes associated with FMT in paediatric IBD. Methods We performed a retrospective review of FMT at 20 paediatric centres in the USA from March 2012 to March 2020. Children with and without IBD were compared with determined differences in the efficacy of FMT for rCDI. In addition, children with IBD with and without a successful outcome were compared with determined predictors of success. Safety data and IBD-specific outcomes were obtained. Results A total of 396 paediatric patients, including 148 with IBD, were included. Children with IBD were no less likely to have a successful first FMT then the non-IBD affected cohort [76% vs 81%, p = 0.17]. Among children with IBD, patients were more likely to have a successful FMT if they received FMT with fresh stool [p = 0.03], were without diarrhoea prior to FMT [p = 0.03], or had a shorter time from rCDI diagnosis until FMT [p = 0.04]. Children with a failed FMT were more likely to have clinically active IBD post-FMT [p = 0.002] and 19 [13%] patients had an IBD-related hospitalisation in the 3-month follow-up. Conclusions Based on the findings from this large US multicentre cohort, the efficacy of FMT for the treatment of rCDI did not differ in children with IBD. Failed FMT among children with IBD was possibly related to the presence of clinically active IBD.
Standardized Autonomic Testing in Patients With Probable Radiation-Induced Afferent Baroreflex Failure
Lamotte, Guillaume , Coon, Elizabeth A., Suarez, Mariana D., Sandroni, Paola, Benarroch, Eduardo, Cutsforth‐Gregory, Jeremy K. , Mauermann, Michelle L., Berini, Sarah E., Shouman, Kamal, Sletten, David, Goodman, Brent P., Low, Phillip A., Mauermann, Michelle L. , Singer, Wolfgang , Mauermann, Michelle L , Lamotte, Guillaume , Coon, Elizabeth A., Suarez, Mariana D., Sandroni, Paola, Benarroch, Eduardo, Cutsforth-Gregory, Jeremy K , Berini, Sarah E., Shouman, Kamal, Sletten, David, Goodman, Brent P., Low, Phillip A.

Mayo Clinic

Hypertension | November 5, 2021 | Volume: 79 | Issue: 1 | Pages: 50-56

10.1161/hypertensionaha.121.17805 | PMID 34739766 Get It

Injury of the afferent limb of the baroreflex from neck radiation causes radiation-induced afferent baroreflex failure (R-ABF). Identification and management of R-ABF is challenging. We aimed to investigate the pattern of autonomic dysfunction on standardized autonomic testing in patients with probable R-ABF. We retrospectively analyzed all autonomic reflex screens performed at Mayo Clinic in Rochester, MN, between 2000 and 2020 in patients with probable R-ABF. Additional tests reviewed included ambulatory blood pressure monitoring, plasma norepinephrine, and thermoregulatory sweat test. We identified 90 patients with probable R-ABF. Median total composite autonomic severity score (range, 0–10) was 7 (interquartile range, 6–7). Cardiovascular adrenergic impairment was seen in 85 patients (94.4%), increased blood pressure recovery time after Valsalva maneuver in 71 patients (78.9%; median 17.4 seconds), and orthostatic hypotension in 68 patients (75.6%). Cardiovagal impairment was demonstrated by abnormal heart rate responses to deep breathing (79.5%), Valsalva ratio (87.2%), and vagal baroreflex sensitivity (57.9%). Plasma norepinephrine was elevated and rose appropriately upon standing (722–1207 pg/mL). Ambulatory blood pressure monitoring revealed hypertension, postural hypotension, hypertensive surges, tachycardia, and absence of nocturnal dipping. Blood pressure lability correlated with impaired vagal baroreflex function. Postganglionic sympathetic sudomotor function was normal in most cases; the most frequent thermoregulatory sweat test finding was focal neck anhidrosis (78.9%). Standardized autonomic testing in R-ABF demonstrates cardiovascular adrenergic impairment with orthostatic hypotension, blood pressure lability, and elevated plasma norepinephrine. Cardiovagal impairment is common, while sudomotor deficits are limited to direct radiation effects.